Format

Send to

Choose Destination
Rheumatology (Oxford). 2015 Feb;54(2):371-2. doi: 10.1093/rheumatology/keu435. Epub 2014 Dec 5.

Treatment of systemic sclerosis with tocilizumab.

Author information

1
Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
2
Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
3
Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal jose.alves@fcm.unl.pt.
PMID:
25480809
DOI:
10.1093/rheumatology/keu435
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center